[go: up one dir, main page]

AR027237A1 - Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico como tambien medicamento que lascontiene. - Google Patents

Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico como tambien medicamento que lascontiene.

Info

Publication number
AR027237A1
AR027237A1 ARP010100207A ARP010100207A AR027237A1 AR 027237 A1 AR027237 A1 AR 027237A1 AR P010100207 A ARP010100207 A AR P010100207A AR P010100207 A ARP010100207 A AR P010100207A AR 027237 A1 AR027237 A1 AR 027237A1
Authority
AR
Argentina
Prior art keywords
medicinal
procedure
preparation
benzoilguanidinas
diagnosis
Prior art date
Application number
ARP010100207A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR027237A1 publication Critical patent/AR027237A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Benzoílguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico, como también medicamento que lascontiene. Las benzoílguanidinas de la Formula 1: en la cual R1 a R4 tienen los significados indi cados en las reivindicaciones, son adecuadas como medicamentoantiarrítmico con componentes cardioprotectores para la profilaxis del infarto y para el tratamiento del infarto, como también para el tratamiento de laangina pectoral. También inhiben pre ventivamente los procesos patofisiologicos al originarse lesiones inducidas isquémicamente, en especial al presentarsearritmias cardiacas inducidas insquémicamente.
ARP010100207A 2000-01-19 2001-01-17 Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico como tambien medicamento que lascontiene. AR027237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10001879A DE10001879A1 (de) 2000-01-19 2000-01-19 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
AR027237A1 true AR027237A1 (es) 2003-03-19

Family

ID=7627855

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100207A AR027237A1 (es) 2000-01-19 2001-01-17 Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico como tambien medicamento que lascontiene.

Country Status (26)

Country Link
US (1) US6703411B2 (es)
EP (1) EP1259481B1 (es)
JP (1) JP4880849B2 (es)
KR (1) KR100726701B1 (es)
CN (1) CN1184196C (es)
AR (1) AR027237A1 (es)
AT (1) ATE530518T1 (es)
AU (1) AU780466B2 (es)
BR (1) BR0107660A (es)
CA (1) CA2397531A1 (es)
CZ (1) CZ20022465A3 (es)
DE (1) DE10001879A1 (es)
EE (1) EE200200381A (es)
HR (1) HRP20020592A2 (es)
HU (1) HUP0204095A3 (es)
IL (1) IL150740A0 (es)
MX (1) MXPA02006431A (es)
NO (1) NO20023383L (es)
NZ (1) NZ520213A (es)
PL (1) PL356589A1 (es)
RU (1) RU2267486C2 (es)
SK (1) SK10382002A3 (es)
TW (1) TWI240718B (es)
WO (1) WO2001053256A1 (es)
YU (1) YU52202A (es)
ZA (1) ZA200205696B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204989A1 (de) * 2002-02-07 2003-08-21 Aventis Pharma Gmbh Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US20050124666A1 (en) 2003-11-13 2005-06-09 Aventis Pharma Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2689058B2 (ja) * 1992-11-02 1997-12-10 新日本製鐵株式会社 塗装体の乾燥・焼付装置
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430916A1 (de) 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19529612A1 (de) 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19608161A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19624178A1 (de) 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
US20010016596A1 (en) 2001-08-23
WO2001053256A1 (de) 2001-07-26
EE200200381A (et) 2003-12-15
DE10001879A1 (de) 2001-07-19
MXPA02006431A (es) 2002-11-29
ATE530518T1 (de) 2011-11-15
US6703411B2 (en) 2004-03-09
AU780466B2 (en) 2005-03-24
NO20023383D0 (no) 2002-07-12
BR0107660A (pt) 2002-11-19
EP1259481A1 (de) 2002-11-27
SK10382002A3 (sk) 2003-04-01
IL150740A0 (en) 2003-02-12
CN1184196C (zh) 2005-01-12
JP4880849B2 (ja) 2012-02-22
KR100726701B1 (ko) 2007-06-13
CN1395558A (zh) 2003-02-05
RU2267486C2 (ru) 2006-01-10
NZ520213A (en) 2004-08-27
HK1051853A1 (en) 2003-08-22
HRP20020592A2 (en) 2004-08-31
JP2003520267A (ja) 2003-07-02
KR20020073175A (ko) 2002-09-19
AU2373201A (en) 2001-07-31
HUP0204095A2 (hu) 2003-04-28
EP1259481B1 (de) 2011-10-26
ZA200205696B (en) 2003-11-26
HUP0204095A3 (en) 2005-05-30
TWI240718B (en) 2005-10-01
YU52202A (sh) 2006-01-16
CA2397531A1 (en) 2001-07-26
PL356589A1 (en) 2004-06-28
NO20023383L (no) 2002-09-03
RU2002122089A (ru) 2004-01-10
CZ20022465A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
Lunagariya et al. Marine natural product bis-indole alkaloid caulerpin: Chemistry and biology
UY28489A1 (es) Glucopiranosiloxi-pirazoles, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparación
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
ECSP088323A (es) Derivados de fenil-[1,2,4]-oxadiazol-5-ona con grupo fenilo, procedimientos para su preparación y su uso como productos farmacéuticos
ECSP066855A (es) Derivados de benceno sustituidos por glucopiranosilo, medicamentos que contienen esos compuestos, su aplicación y procedimiento para su preparación
WO2004103150A3 (en) Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
ES2143122T3 (es) Sulfonimidamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
BR112012033666A2 (pt) formulações para alimentação por tubo e métodos de uso das mesmas
PA8574701A1 (es) Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen
MY139310A (en) Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as. medicament or diagnostic aid, and medicament comprising them
AR027237A1 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o medio de diagnostico como tambien medicamento que lascontiene.
ES2168324T3 (es) Benzoilguanidinas sustituidas con heterociclos-n-oxidos, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico, asi como medicamento que las contiene.
Littmann et al. ST-segment elevation: a common finding in severe hypercalcemia
UY31118A1 (es) Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden
GB0412019D0 (en) Organic compounds
BRPI0413798A (pt) benzoilguanidinas substituìdas por pentafluorsulfanilfenila, processo para sua preparação, seu emprego como medicamento ou diagnóstico, assim como medicamento contendo-as
DOP2004001028A (es) Pentafluorosulfanilbenzoilguanidinas, procedimiento para su preparacion, su uso como medicamento o coadyuvante de diagnostico, y medicamento que las comprende
AR026179A1 (es) Benzoilguanidinas heterociclicamente sustituidas, procedimiento para su preparacion, su empleo como medicamentos o medios de diagnostico asi como los medicamentos que las contienen
ES2158383T3 (es) Guanididas de acidos tiofenil-alquenil-carboxilicos sustituidos, procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como medicamento que las contiene.
AR007497A1 (es) Benzoilguanidinas bis-orto-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamentoque las contiene
AR004318A1 (es) Benzoil-guanidinas sustituidas con sulfonilamino, procedimiento para su preparacion, su empleo como medicamento o para diagnostico, asi como elmedicamento que las contiene.
UY28487A1 (es) Benzoilguanidinas sustituidas con pentafluorosulfanilfenilo, procedimientos para su preparación, su uso como medicamento o coadyuvante de diagnóstico y el medicamento que las comprende.
ES2146348T3 (es) Cromanilsulfonil(tio)ureas sustituidas, procedimiento para su preparacion y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen.
ES2140922T3 (es) Benzoilguanidinas orto-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.

Legal Events

Date Code Title Description
FB Suspension of granting procedure